CC Chemokine Receptor 5 Targeted Nanoparticles Imaging the Progression and Regression of Atherosclerosis Using Positron Emission Tomography/Computed Tomography-Reference-Cited by-同舟云学术

CC Chemokine Receptor 5 Targeted Nanoparticles Imaging the Progression and Regression of Atherosclerosis Using Positron Emission Tomography/Computed Tomography

Published:2021-02-16 Issue:3 Volume:18 Page:1386-1396
ISSN:1543-8384
Container-title:Molecular Pharmaceutics
language:en
Short-container-title:Mol. Pharmaceutics

Author:

Detering Lisa¹,Abdilla Allison²,Luehmann Hannah P.¹,Williams Jesse W.³,Huang Li-Hao³,Sultan Deborah¹,Elvington Andrew³,Heo Gyu Seong¹^ORCID,Woodard Pamela K.¹,Gropler Robert J.¹,Randolph Gwendalyn J.³,Hawker Craig J.²^ORCID,Liu Yongjian¹^ORCID

Affiliation:

1. Mallinckrodt Institute of Radiology, Washington University, St. Louis, Missouri 63110, United States

2. Materials Department, University of California, Santa Barbara, California 93106, United States

3. Department of Pathology and Immunology, Washington University, St. Louis, Missouri 63110, United States

Funder

National Heart, Lung, and Blood Institute

National Science Foundation

Publisher

American Chemical Society (ACS)

Subject

Drug Discovery,Pharmaceutical Science,Molecular Medicine

Link